News and Events
In the News
The Slow Reveal
- Managed Care Magazine
Rebates have created pay-to-play dynamics. Employers facing high drug costs have “rebate addiction.” And the impressive “rebate guarantees” are hard to resist. But at least the process of how drugs get formulary placement is becoming clearer, and some PBMs have moved to charging administrative fees only.
Small PBMs Urge Congress: Don't Kill Rebates
Smaller pharmacy benefit management companies, rarely in the spotlight, are urging Congress not to fundamentally alter the way prescription drugs are paid for in the U.S. As the Trump administration advocates banning rebates under Medicare and Medicaid, these lower-profile PBMs aim to convince lawmakers not to junk the entire system. They say Congress should start by examining business models other than just of the nation's largest PBM players.
Policy Makers Seek Answers for High Costs of Prescription Drugs
- Pharmacy Times
Members of Congress sought to deconstruct the drug supply chain Thursday in an effort to find ways to lower prescription drug prices. Hosted by the House Committee on Energy & Commerce, the investigational hearing drew testimony from health care industry experts representing drug companies, insurers, and patient advocacy groups.